Apyx Medical (APYX) Other Non-Current Liabilities (2010 - 2026)
Apyx Medical's (APYX) quarterly Other Non-Current Liabilities came in at $336000.0 in Q2 2026, up 15.07% on a YoY basis from $292000.0 in Q2 2025, and down 0.88% quarter-over-quarter from $339000.0 in Q1 2026.
Powered by 
Analysis
Apyx Medical (APYX) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Apyx Medical (APYX) has reported Other Non-Current Liabilities for 17 consecutive years, with $336000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Liabilities rose 15.07% year-over-year to $336000.0; the trailing twelve-month figure through Jun 2026 stood at $336000.0 (up 15.07% YoY), and the FY2025 full-year result was $347000.0, up 33.98% from the prior year.
- Other Non-Current Liabilities eased to $336000.0 in Q2 2026 per APYX's latest filing, from $339000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $347000.0 in Q4 2025 and bottomed at $133000.0 in Q3 2022.
- Historically, Other Non-Current Liabilities has averaged $226611.1 across 5 years, with a median of $196000.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities decreased 8.9% in 2022, then surged 52.08% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $181000.0 in 2022, then climbed by 9.39% to $198000.0 in 2023, then jumped by 30.81% to $259000.0 in 2024, then jumped by 33.98% to $347000.0 in 2025, then fell by 3.17% to $336000.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $336000.0, $339000.0, and $347000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.77 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.65 Bn | 122.43 Bn | 1.96 Bn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.46 Bn | 62.92 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn |
| 7 | Alcon | 33.01 Bn | 31.56 Bn | 1.68 Bn |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn |
| 10 | Apyx Medical | 130.67 Mn | 103.06 Mn | 8.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 336,000.00 |
| Mar 31, 2026 | 339,000.00 |
| Dec 31, 2025 | 347,000.00 |
| Sep 30, 2025 | 293,000.00 |
| Jun 30, 2025 | 292,000.00 |
| Mar 31, 2025 | 270,000.00 |
| Dec 31, 2024 | 259,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Jun 30, 2024 | 192,000.00 |
| Mar 31, 2024 | 194,000.00 |
| Dec 31, 2023 | 198,000.00 |
| Sep 30, 2023 | 181,000.00 |
| Jun 30, 2023 | 185,000.00 |
| Mar 31, 2023 | 185,000.00 |
| Dec 31, 2022 | 181,000.00 |
| Sep 30, 2022 | 133,000.00 |
| Jun 30, 2022 | 142,000.00 |
| Mar 31, 2022 | 151,000.00 |
| Dec 31, 2021 | 166,000.00 |
| Sep 30, 2021 | 146,000.00 |